ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
24.34
-0.30 (-1.24%)
Nov 21, 2025, 4:00 PM EST
ResMed Market Cap
ResMed has a market cap or net worth of $36.6 billion as of November 24, 2025. Its market cap has increased by 0.35% in one year.
Market Cap
36.60B
Enterprise Value
36.06B
Revenue
5.26B
Ranking
n/a
PE Ratio
25.45
Stock Price
$24.34
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 38.59M to 36.60B, an increase of 94,739.80%. That is a compound annual growth rate of 25.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 36.57B | 8.89% |
| Dec 31, 2024 | 33.58B | 32.73% |
| Dec 29, 2023 | 25.30B | -17.24% |
| Dec 30, 2022 | 30.57B | -19.72% |
| Dec 31, 2021 | 38.08B | 23.63% |
| Dec 31, 2020 | 30.80B | 38.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 555.46M |
| Glass House Brands | 520.88M |
| CytoDyn | 384.62M |
| Northwest Biotherapeutics | 383.27M |
| American Oncology Network | 346.66M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 298.05M |